November 24, 2025 - 19:07

In its latest financial disclosure, the company announced a total revenue of $1,229.8 million for the third quarter, reflecting a year-over-year increase of 4.4%. When adjusted for constant currency, the growth stands at 4.2%. The enterprise segment performed particularly well, generating $741.4 million in revenue, which marks a 6.1% increase compared to the same period last year.
The operating margins also showed significant strength, with a GAAP operating margin of 25.2% and a non-GAAP operating margin reaching 41.2%. The company reported impressive operating cash flow of $629.3 million, representing a 30.2% increase year over year. This resulted in an operating cash flow margin of 51.2% and a free cash flow margin of 50.0%.
Earnings per share (EPS) saw remarkable growth, with a GAAP EPS of $2.01, reflecting an extraordinary increase of 204.5% year over year. The financial results underscore the company's robust performance and strategic positioning in the market.
October 9, 2026 - 23:32
Chancellor Placed on Leave Following Financial Misconduct ClaimsThe chancellor of a San Francisco college has been placed on administrative leave while officials examine allegations of financial misconduct. The decision was announced as a temporary measure, and...
October 9, 2026 - 09:12
Finance Hiring Still Favors Degree Holders for Top Paying RolesRecruiters filling the highest paying jobs in finance continue to treat a university degree as a basic requirement, even as some employers experiment with skills based hiring. The preference is...
October 8, 2026 - 18:33
Enova Announces Date of Third Quarter 2026 Financial Results Conference CallEnova International has scheduled the release of its third quarter 2026 financial results for Thursday, October 22, 2026. The company will publish the report after the stock market closes that day,...
October 8, 2026 - 08:18
Celcuity (CELC) Is Down 17.3% After REVTORPYK US Launch And sNDA Filing News EventCelcuity Inc. saw its shares drop 17.3 percent after the company announced two significant developments regarding its breast cancer treatment. The company confirmed that REVTORPYK, also known as...